They might still be paying for licensing the product, however everything with Viaderma is a big ass TBD. We'll only see in the filings which are almost always late.
$1 million on the books? Any inventory on the books? International sales on the books? New state licensing deals on the books? Anything new?
Not sure but I understand your point. However, business is business... It wont affect the contract they have on the license deals, I would not worry on that side. One thing they are associated and another is getting a contract on a product
News 
Market Data 
Discover 
